DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Klonopin (Clonazepam) - Published Studies


Klonopin Related Published Studies

Well-designed clinical trials related to Klonopin (Clonazepam)

Comparing Gabapentin with Clonazepam for Residual Sleeping Problems following Antidepressant Therapy in Patients with Major Depressive Disorder: A Randomized Clinical Trial. [2015]

A double-blind study on clonazepam in patients with burning mouth syndrome. [2012]

Comparing effects of clonazepam and zolpidem on sleep quality of patients on maintenance hemodialysis. [2011]

Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory, post-hoc analysis of a randomized, double blind study. [2010.01]

Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory, post-hoc analysis of a randomized, double blind study. [2010]

Pharmacokinetic/pharmacodynamic modeling of psychomotor impairment induced by oral clonazepam in healthy volunteers. [2009.10]

Defense style changes with the addition of psychodynamic group therapy to clonazepam in social anxiety disorder. [2009.07]

Clonazepam quantification in human plasma by high-performance liquid chromatography coupled with electrospray tandem mass spectrometry in a bioequivalence study. [2007.01]

Clonazepam for treatment of sleep disturbances associated with combat-related posttraumatic stress disorder. [2004.09]

A double-blind combination study of clonazepam with sertraline in obsessive-compulsive disorder. [2004.07]

Topical clonazepam in stomatodynia: a randomised placebo-controlled study. [2004.03]

Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis. [2004.03]

Double-blind, placebo-controlled assessment of combined clonazepam with paroxetine compared with paroxetine monotherapy for generalized social anxiety disorder. [2004.02]

Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder. [2003.09]

A double-blind, placebo-controlled trial of clonazepam in obsessive-compulsive disorder. [2003.01]

Comparative single-dose pharmacokinetics of clonazepam following intravenous, intramuscular and oral administration to healthy volunteers. [2003]

Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression? [2002.08]

The effectiveness of adding pharmacologic treatment with clonazepam or cyclobenzaprine to patient education and self-care for the treatment of jaw pain upon awakening: a randomized clinical trial. [2002.01]

Early coadministration of clonazepam with sertraline for panic disorder. [2001.07]

Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD): acute placebo-controlled sleep laboratory studies with clonazepam. [2001.04]

Double-blind clonazepam vs placebo in panic disorder treatment. [2000.12]

Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression. [2000.12]

Comparative bioavailability study of clonazepam after oral administration of two tablet formulations. [2000.10]

A comparison of the efficacy of clonazepam and cognitive-behavioral group therapy for the treatment of social phobia. [2000.07]

Double-blind acute clonazepam vs. placebo in carbon dioxide-induced panic attacks. [2000.05.15]

Reduction of epileptiform activity in response to low-dose clonazepam in children with epilepsy: a randomized double-blind study. [2000.03]

Clonazepam and sertraline: absence of drug interaction in a multiple-dose study. [2000.02]

Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages. [1999.09]

Carbon dioxide induced panic attacks and short term clonazepam treatment. Preliminary study. [1999.06]

Clonazepam treatment of panic disorder in patients with recurrent chest pain and normal coronary arteries. [1999]

Discontinuation of clonazepam in the treatment of social phobia. [1998.10]

Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study. [1998.10]

Clonazepam in the treatment of panic disorder with or without agoraphobia: a dose-response study of efficacy, safety, and discontinuance. Clonazepam Panic Disorder Dose-Response Study Group. [1997.10]

The effects of clonazepam on quality of life and work productivity in panic disorder. [1997.08]

The effectiveness of clonazepam on the Rolandic discharges. [1997.06]

Comparison of cognitive-behavioral therapy and clonazepam for treating periodic limb movement disorder. [1996.06]

Treatment of manic episodes: zuclopenthixol and clonazepam versus lithium and clonazepam. [1996.02]

The relationship of alprazolam and clonazepam dose to steady-state concentration in plasma. [1994.08]

A double-blind comparison of clonazepam and placebo in the treatment of neuroleptic-induced akathisia. [1994.06]

Clonazepam in the treatment of panic disorder: a double-blind, placebo-controlled trial investigating the correlation between clonazepam concentrations in plasma and clinical response. [1994.04]

Clonazepam in childhood anxiety disorders. [1994.03]

Treatment of social phobia with clonazepam and placebo. [1993.12]

A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms. [1993.11]

Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder. [1993.08]

Phenobarbital versus clonazepam for sedative-hypnotic taper in chronic pain patients. A pilot study. [1993.06]

Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder. [1992.12]

Fluoxetine impairs clearance of alprazolam but not of clonazepam. [1992.11]

Usefulness of antiparkinsonian drugs during neuroleptic treatment and the effect of clonazepam on akathisia and parkinsonism occurred after antiparkinsonian drug withdrawal: a double-blind study. [1992.09]

Clonazepam in acute mania: a double blind trial. [1991.06]

Administration of clonazepam in the treatment of TMD and associated myofascial pain: a double-blind pilot study. [1991.06]

Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. [1991.02]

Effects of the anticonvulsant benzodiazepine clonazepam on event-related brain potentials in humans. [1991.02]

Double-blind comparison of the effects of clonazepam and lorazepam in acute mania. [1990.12]

Clonazepam in the treatment of social phobia: a pilot study. [1990.05]

Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy. [1990.04]

Clonazepam vs. neuroleptics as adjuncts to lithium maintenance. [1990]

Successful clonazepam treatment of neuroleptic-induced akathisia in older adolescents and young adults: a double-blind, placebo-controlled study. [1989.12]

Effects of clobazam and clonazepam on saccadic eye movements and other parameters of psychomotor performance. [1989]

Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial. [1987.10]

Well-designed clinical trials possibly related to Klonopin (Clonazepam)

Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients with bipolar disorder: a randomized double blind placebo controlled clinical trial. [2014]

Evaluation of anti-hyperalgesic and analgesic effects of two benzodiazepines in human experimental pain: a randomized placebo-controlled study. [2013]

A prehospital randomized trial in convulsive status epilepticus. [2011.10]

Carbon dioxide induction of panic anxiety in schizophrenia with auditory hallucinations. [2011.08.30]

Benefit effect of naloxone in benzodiazepines intoxication: findings of a preliminary study. [2011.07]

Oral pharmacological treatment of X-linked dystonia parkinsonism: successes and failures. [2011]

Carbon dioxide induction of panic anxiety in schizophrenia with auditory hallucinations. [2011]

The acute and late CNS glutamine response to benzodiazepine challenge: a pilot pharmacokinetic study using proton magnetic resonance spectroscopy. [2010.12.30]

A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder. [2010.12]

Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation. [2010.08]

A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder. [2010.06.16]

Effect of lingual nerve block on burning mouth syndrome (stomatodynia): a randomized crossover trial. [2010.04]

Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial. [2009.11]

Benzodiazepines and GABAergics in treating severe disabling tinnitus of predominantly cochlear origin. [2006]

Effects of group experiential cognitive therapy for the treatment of panic disorder with agoraphobia. [2005.08]

Changes in anxiety sensitivity with pharmacotherapy for panic disorder. [2004.09]

Naltrexone treatment of tardive dyskinesia in patients with schizophrenia. [2004.08]

Assessment of single-dose benzodiazepines on insulin secretion, insulin sensitivity and glucose effectiveness in healthy volunteers: a double-blind, placebo-controlled, randomized cross-over trial [ISRCTN08745124]. [2004.03.04]

Second-line anticonvulsant treatment of neonatal seizures: a video-EEG monitoring study. [2004.02.10]

Correlates of therapeutic response in panic disorder presenting with palpitations: heart rate variability, sleep, and placebo effect. [2003.07]

Therapeutic response to benzodiazepine in panic disorder subtypes. [2003.03.05]

Carbon dioxide test as an additional clinical measure of treatment response in panic disorder. [2002.06]

[May results from randomized clinical trials be generalized? An example from psychopharmacology] [1998.07.20]

Validation of the Bech-Rafaelsen Mania Scale using latent structure analysis. [1997.11]

Generalisability of results from randomised drug trials. A trial on antimanic treatment. [1997.03]

[High dose ifosfamide at 15 g/m2/cycle: a feasibility study in 10 patients] [1997.02]

Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. [1996.03]

Anticonvulsant drugs for management of pain: a systematic review. [1995.10.21]

Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. [1993.10]

Treatment of spasticity in children with low dose benzodiazepine. [1993.07]

Effectiveness of piracetam in cortical myoclonus. [1993]

A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation. [1990]

Pharmacological study in Meige's syndrome with predominant blepharospasm. [1988.02]

Other research related to Klonopin (Clonazepam)

Comparing effects of clonazepam and zolpidem on sleep quality of patients on maintenance hemodialysis. [2011.11]

Semi-solid dosage form of clonazepam for rapid oral mucosal absorption. [2011.07]

Administration of the combination clonazepam-Deanxit as treatment for tinnitus. [2011.06]

Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine. [2011.04]

Combined topical and systemic clonazepam therapy for the management of burning mouth syndrome: a retrospective pilot study. [2011.03]

Comparison of two oral symptom-triggered pharmacological inpatient treatments of acute alcohol withdrawal: clomethiazole vs. clonazepam. [2011.01]

Administration of the combination clonazepam-Deanxit as treatment for tinnitus. [2011]

Effects of insulin and clonazepam on DNA damage in diabetic rats submitted to the forced swimming test. [2010.12.21]

Dissolving oral clonazepam wafers in the acute treatment of prolonged seizures. [2010.12]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017